Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

Hiroaki Ogata, Yuzo Yamamoto, Taishi Harada, Yoichi Nakanishi, Isamu Okamoto, Eiji Iwama, Eiji Iwama, Koji Kato, Yoshinao Oda

Research output: Contribution to journal › Letter

Original languageEnglish
Pages (from-to)e46-e47
JournalJournal of Thoracic Oncology
Volume12
Issue number5
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Aplastic Anemia
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Therapeutics
osimertinib

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer. / Ogata, Hiroaki; Yamamoto, Yuzo; Harada, Taishi; Nakanishi, Yoichi; Okamoto, Isamu; Iwama, Eiji; Iwama, Eiji; Kato, Koji; Oda, Yoshinao.

In: Journal of Thoracic Oncology, Vol. 12, No. 5, 01.05.2017, p. e46-e47.

Research output: Contribution to journal › Letter

Ogata, H, Yamamoto, Y, Harada, T, Nakanishi, Y, Okamoto, I, Iwama, E, Iwama, E, Kato, K & Oda, Y 2017, 'Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer', Journal of Thoracic Oncology, vol. 12, no. 5, pp. e46-e47. https://doi.org/10.1016/j.jtho.2016.12.023
Ogata H, Yamamoto Y, Harada T, Nakanishi Y, Okamoto I, Iwama E et al. Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 2017 May 1;12(5):e46-e47. https://doi.org/10.1016/j.jtho.2016.12.023
Ogata, Hiroaki ; Yamamoto, Yuzo ; Harada, Taishi ; Nakanishi, Yoichi ; Okamoto, Isamu ; Iwama, Eiji ; Iwama, Eiji ; Kato, Koji ; Oda, Yoshinao. / Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer. In: Journal of Thoracic Oncology. 2017 ; Vol. 12, No. 5. pp. e46-e47.
@article{a9b22e0b1bd44afcb823a81a5434d936,
title = "Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer",
author = "Hiroaki Ogata and Yuzo Yamamoto and Taishi Harada and Yoichi Nakanishi and Isamu Okamoto and Eiji Iwama and Eiji Iwama and Koji Kato and Yoshinao Oda",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.jtho.2016.12.023",
language = "English",
volume = "12",
pages = "e46--e47",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "5",

}

TY - JOUR

T1 - Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

AU - Ogata, Hiroaki

AU - Yamamoto, Yuzo

AU - Harada, Taishi

AU - Nakanishi, Yoichi

AU - Okamoto, Isamu

AU - Iwama, Eiji

AU - Iwama, Eiji

AU - Kato, Koji

AU - Oda, Yoshinao

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85017658108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017658108&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2016.12.023

DO - 10.1016/j.jtho.2016.12.023

M3 - Letter

VL - 12

SP - e46-e47

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 5

ER -

Access to Document